Insider trade report
Open the filing on sec.gov
Myriad Genetics, Inc. (MYGN)
Nasdaq: MYGN · In Vitro & In Vivo Diagnostic Substances · Salt Lake City, UT · filing with the SEC since 1996
The companyfiscal 2025, as filed
Revenue$825M-1.6%
Net income-$366M-187.4%
Earnings per share$-3.95-180.1%
Operating cash flow$1.8M+120.7%
Cash$150M+46.1%
Debt$120M+202.8%
Shareholders’ equity$368M-47.5%
Shares, diluted92.6M+2.2%
Return on equity-99.4%
The recordfrom its filings
Filings in 202689
Newest filingNov 9 · 4
Annual reportFeb 24, 2026
Quarterly reportNov 6, 2026
Next report due10-K by Mar 16
Insider sales, 12 months$100,000
Insider buys, 12 months$700,000
Patents granted121
Filer categoryAccelerated filer
Trailing twelve months to Sep 2026Revenue $804MNet income -$129MCash from operations -$19.9Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in USD. Nothing here is a forecast.
The company now
Myriad Genetics agreed on 19 October 2026 to sell its prenatal health testing business to Laboratory Corporation of America for $210 million in cash, plus the value of the inventory at closing 4.
The companies expect the deal to close by early 2027, subject to regulatory clearance 3.
The sale follows a weak second quarter, when revenue of $190.7 million fell 11 percent from a year earlier 2.
The company said lower prenatal test volumes and weaker revenue per test led it to cut its 2026 guidance 2.
Management called the sale the direct outcome of a strategic review and said it would strengthen the balance sheet 3.
As of Oct 28, 2026. Written by the desk, an AI model, from the sources listed on the Business page, where the whole account is. Nothing here is advice.
Newer filings are on file since this was written; an update is queued.
News
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Quarterly report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.